Navigation Links
Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
Date:2/14/2008

- New Data Presented at American Society of Clinical Oncology's

Genitourinary Symposium -

SEATTLE and SAN FRANCISCO, Feb. 14 /PRNewswire-FirstCall/ -- Researchers from Dendreon Corporation (Nasdaq: DNDN) today presented data demonstrating the correlation of a measure of the cumulative potency of PROVENGE (sipuleucel-T), an investigational active cellular immunotherapy for hormone-refractory prostate cancer, with overall survival. This is the first time that an association between higher potency of an active immune therapy and increased patient survival has been reported. The correlation appeared to be independent of other important baseline prognostic factors.

The abstract (#21), "Cell Number and CD54 Expression in Sipuleucel-T Correlate with Survival in Metastatic Androgen Independent Prostate Cancer," is being presented at the American Society of Clinical Oncology's 2008 Genitourinary Symposium in San Francisco.

In two Phase 3 trials, D9901 and D9902A, researchers evaluated cumulative product release parameters of PROVENGE, including CD54 upregulation (a measure of product potency defined as the increase of CD54 molecules expressed on Antigen Presenting Cells [APC] after incubation with the PROVENGE Antigen Delivery Cassette(TM)) and the number of total nucleated cells (TNCs) among patients treated with sipuleucel-T (n=146). CD54 is a costimulatory molecule which serves as a marker for APCs. Its expression is increased when APCs become activated and this upregulation of CD54 serves as a potency release assay for PROVENGE.

Results showed that PROVENGE patients experienced improved survival if they received more cells across the three doses of PROVENGE (higher cumulative TNC count (
'/>"/>

SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
5. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
6. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
7. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
8. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
9. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
10. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
11. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 26, 2014 Scott Steiger lives in ... world. As an engineer for the past 20 years, he,s traveled ... military service. He,s been to six of the seven continents. Travel ... - http://photos.prnewswire.com/prnh/20141126/161076 Photo - http://photos.prnewswire.com/prnh/20141126/161077 ... has a pretty good idea of what,s required. His ...
(Date:11/26/2014)... A hernia is condition in which a tissue, ... of a weak muscle area. Obesity, poor nutrition, smoking, and ... causes of hernias. There are several types of hernia such ... is when part of the abdominal tissue/organ protrudes into the ... of the umbilicus. A hiatal hernia is when a portion ...
(Date:11/26/2014)... 2014  CARsgen, a leader in the development of ... a variety of cancers, today announced the completion of ... China -based healthcare private equity fund.   ... the development of new therapeutics for liver, lung, stomach ... and Shanghai Renji Hospital, the company plans to initiate ...
Breaking Medicine Technology:Steiger Has Created the First Pill Case Specifically Designed For Travel 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4CARsgen Completes Series A Financing 2
... 2, 2010 CSA Medical, Inc. ( www.CSAmedical.com ) ... incoming president, CEO and member of the board of ... years of medical device experience, including market development roles ... "We are thrilled to have Bill join ...
... Dec. 2, 2010 Sagent Pharmaceuticals, Inc., a ... approval of four presentations of midazolam injection, USP, ... which will be offered in latex-free vials, in ... U.S. market for injectable midazolam approximated $52 million. ...
Cached Medicine Technology:CSA Medical Appoints William H. Floyd President and CEO 2Sagent Pharmaceuticals Announces FDA Approval of Midazolam Injection, USP 2
(Date:11/28/2014)... CA (PRWEB) November 28, 2014 ... on December 2, 2014. This national movement was created ... communities by giving to local charities and causes. ... Holiday, coincides with the kickoff of the holiday shopping ... is to shopping and Cyber Monday is to online ...
(Date:11/28/2014)... November 28, 2014 Dr. Diane Walder, ... , announced the addition of Dr. Bridgit Nolan to ... the practice after having completed her dermatology residency at ... Dr. Walder invited Dr. Nolan to join ... surgery and cosmetic dermatology. Not only does Dr. Nolan ...
(Date:11/28/2014)... Dr. Diane Walder, one of South Florida’s top ... practice called Ultrashape that is designed to help her patients ... six weeks. Ultrashape has been praised by patients as being ... compared to other types of external fat reduction. , “If ... Walder. , According to Dr. Walder, Ultrashape works by ...
(Date:11/28/2014)... Written and narrated by award winning author Dr. James ... Happiest Man In the World: Life Lessons From a Cultural ... Project C.U.R.E. came to be. , Raised in the Boise ... Richard W. Jackson, Dr. Jackson exceeded his goal of being ... he wasn’t happy. Prompted by this realization, James and his ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 ... testing and treatment, helped employees learn their risk ... diabetes blood screening at a local school in ... @ Work initiative. , As the Presenting ... program , PreDiabetes Centers is co-hosting diabetes-prevention presentations ...
Breaking Medicine News(10 mins):Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 3Health News:Dr. Diane Walder Welcomes New Cosmetic Dermatologist to Practice 2Health News:Dr. Diane Walder Introduces New Fat Reduction Treatment Called Ultrashape 2Health News:Dr. Diane Walder Introduces New Fat Reduction Treatment Called Ultrashape 3Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2Health News:PreDiabetes Centers Offers Workplace Diabetes Screening at Local School 2
... are testing a cancer-fighting film that could be applied ... which can be made into any size and shape, ... tumor site as it dissolves over several weeks. This ... ,A paper-thin, biodegradable implant is proving ...
... Biology online on February 8, have developed a small-molecule ... the control of cell division. The researchers show that ... mice and cancer-derived cells growing in culture. ... by two collaborating groups—one (Lenart et al.) led by ...
... to formulate rules on organ donations to foreigners. This ... ,Mr.Mundo emphasized on the need for such guidelines as ... flourishing in the country especially among the poorer sections of ... to set forth a list of guidelines has become necessary ...
... in the journal Blood, allogeneic stem cell transplants are ... ,An allogeneic stem cell transplant is a ... and lymphoma. The process of an allogeneic stem cell ... total body irradiation. These treatment approaches tend to kill ...
... therapy device may help people regain strength and normal ... to a University of California, Irvine study. ... ability to grasp and release objects after therapy sessions ... had at least moderate residual weakness and reduced function ...
... key inflammatory mediators (IL-12 and IL-23) is highly effective//, ... ,Current treatments for psoriasis include topical ... of the disease. Many of these treatments are messy, ... effective, according to Gerald Krueger, M.D., principal investigator for ...
Cached Medicine News:Health News:A Better Way to Deliver Cancer Drugs 2Health News:New Protein Inhibitor Halts Growth Of Cancerous Cells 2Health News:Allogeneic Stem Cell Transplants Linked With Risk for Diabetes and Hypertension 2Health News:Robotic Therapy Helps Restore Hand Use After Stroke 2Health News:Robotic Therapy Helps Restore Hand Use After Stroke 3Health News:New Treatment For Psoriasis Is Highly Effective 2
... selectively removes closures from various sample tubes with ... rack opening in one run. The Decapping Module ... like Sorting System RS 800 (optional), Sorting System ... Aliquoting System RSD 800A. All common primary tubes ...
... Detection Reagents provide molecular labs a more ... By using our MGB technology, combined with ... now able to provide molecular labs more ... of specific organisms or genetic mutations associated ...
... molecular labs a more advanced alternative for ... MGB technology, combined with post-PCR dissociation melt ... provide molecular labs more powerful tools for ... or genetic mutations associated with disease, as ...
... the latest and most advanced fecal occult ... line. An immunochemical FOBT (iFOBT) with high ... proven to detect bleeding associated with more ... Because of its superior specificity for lower ...
Medicine Products: